scispace - formally typeset
Open AccessJournal ArticleDOI

The British Society for Rheumatology Guideline for the Management of Gout.

Reads0
Chats0
About
This article is published in Rheumatology.The article was published on 2017-07-01 and is currently open access. It has received 191 citations till now. The article focuses on the topics: Guideline.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial

TL;DR: Nurse-led gout care is efficacious and cost-effective compared with usual care and the benefits of educating and engaging patients in gout management are illustrated and reaffirm the importance of a treat-to-target urate-lowering treatment strategy to improve patient-centred outcomes.
Journal ArticleDOI

Gout: state of the art after a decade of developments.

TL;DR: It is emphasized that the current epidemiology of gout indicates a rising prevalence worldwide, not only in Western countries but also in Southeast Asia, in close relationship with the obesity and metabolic syndrome epidemics.
Journal ArticleDOI

Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements

TL;DR: Methodological quality needs improvement in guidance documents on gout and hyperuricemia, and promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.
References
More filters
Journal ArticleDOI

Going from evidence to recommendations

TL;DR: The GRADE system classifies recommendations made in guidelines as either strong or weak, and the meaning of these descriptions and their implications for patients, clinicians, and policy makers are explored.
Journal ArticleDOI

Clinical guidelines: Developing guidelines

TL;DR: The five steps in the initial development of an evidence based guideline are considered and the results of their combined experience in guideline development in North America and Britain are presented.
Journal ArticleDOI

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

TL;DR: Although the incidence of gout flares diminished with continued treatment, the overall incidence during weeks 9 through 52 was similar in all groups andFebuxostat, at a daily dose of 80 mg or 120 mg, was more effective than allopurinol at the commonly used fixed daily doses of 300 mg in lowering serum urate.
Related Papers (5)